Newborn Hearing Screening Tests: Otoacoustic Emissions (OAE) and Automated Auditory Brainstem Response (AABR) in the United States

Summary

  • Newborn hearing screening tests are crucial in identifying hearing loss in infants early on.
  • Two common methods used in medical labs in the United States for newborn hearing screening tests are the otoacoustic emissions (OAE) test and the automated auditory brainstem response (AABR) test.
  • Both tests are non-invasive and provide accurate results to help Healthcare Providers determine if further evaluation is needed for a newborn's hearing health.

Introduction

Newborn hearing screening tests are an essential part of early childhood healthcare in the United States. Identifying hearing loss in infants early on can lead to interventions that improve a child's language and communication skills. In medical labs across the country, Healthcare Providers use various methods to perform newborn hearing screening tests. In this article, we will explore two common methods used in the United States and their importance in identifying hearing loss in infants.

Otoacoustic Emissions (OAE) Test

The otoacoustic emissions (OAE) test is a common method used in medical labs in the United States to screen newborns for hearing loss. This test is non-invasive and can be performed in newborns as young as a few hours old. During the test, a small probe is placed in the baby's ear, and sounds are played through the probe. The probe measures the sounds that are produced in the inner ear in response to the sounds played. If the baby's inner ear is functioning correctly, an echo or "emission" of sound will be detected, indicating normal hearing. If no emissions are detected, further evaluation may be needed to determine if hearing loss is present.

Advantages of OAE Test

  1. Non-invasive: The OAE test is a simple and painless procedure that does not require sedation or anesthesia for the baby.
  2. Early detection: The test can be performed shortly after birth, allowing Healthcare Providers to identify hearing loss early on and start interventions as needed.
  3. Accurate results: The OAE test is highly reliable in screening for hearing loss and can help Healthcare Providers determine the next steps in a newborn's care.

Limitations of OAE Test

  1. Outer ear function: The OAE test measures the function of the outer hair cells in the inner ear, so it may not detect certain types of hearing loss.
  2. Environmental factors: External noise or movement during the test can impact the results, so a quiet and calm testing environment is essential for accurate screening.
  3. Follow-up testing: If the OAE Test Results are inconclusive, further testing, such as the automated auditory brainstem response (AABR) test, may be needed to confirm hearing loss.

Automated Auditory Brainstem Response (AABR) Test

The automated auditory brainstem response (AABR) test is another common method used in medical labs in the United States to screen newborns for hearing loss. This test measures the electrical activity of the auditory nerve and brainstem in response to sounds played through earphones placed on the baby's ears. The test is non-invasive and can be performed while the baby is sleeping or resting quietly. If abnormal responses are detected, further evaluation may be needed to confirm hearing loss and determine the next steps in a newborn's care.

Advantages of AABR Test

  1. Objective results: The AABR test provides objective measurements of hearing function, allowing Healthcare Providers to accurately assess a newborn's hearing health.
  2. Quick and efficient: The test can be completed in a short amount of time, making it a practical screening tool for newborns in medical labs.
  3. Sensitive to hearing loss: The AABR test is highly sensitive in detecting hearing loss, even in newborns with minimal symptoms or risk factors.

Limitations of AABR Test

  1. Equipment dependency: The AABR test requires specialized equipment and trained Healthcare Providers to perform the test accurately.
  2. Cost: The equipment and training needed to conduct the AABR test may be costly for some medical labs, limiting access to this screening method in certain healthcare settings.
  3. Follow-up testing: In some cases, additional testing may be needed to confirm the results of the AABR test and determine the appropriate interventions for a newborn with hearing loss.

Conclusion

Newborn hearing screening tests are essential in identifying hearing loss in infants early on to improve their long-term outcomes. In medical labs in the United States, the otoacoustic emissions (OAE) test and the automated auditory brainstem response (AABR) test are two common methods used to screen newborns for hearing loss. Both tests are non-invasive, provide accurate results, and help Healthcare Providers determine if further evaluation is needed for a newborn's hearing health. By utilizing these screening methods appropriately, Healthcare Providers can ensure that newborns with hearing loss receive the interventions and support they need for optimal development.

Improve-Medical--Blood-Collection-Supplies

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos

Previous
Previous

Common Methods for Collecting Urine and Blood Specimens in Medical Labs and Phlebotomy in the United States

Next
Next

Challenges of Implementing Pharmacogenomics Testing in Clinical Practice: Regulatory Requirements, Cost, Education, and Integration